Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,265-3,276 of 10,612

Behavioral study icon

CompletedNCT03478501

Assisting in Decisions in Emergency Departments: (ED-AID) Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralFrom 18 Years to 89 Years

Countries: United States
Sponsor: University of Colorado, Denver
Condition: Suicidality

Behavioral study icon

CompletedNCT02103621

Assisting OCD (OCD) people with Discontinuing Long-term Serotonin Reuptake Inhibitors (SRIs)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 18 Years to 75 Years

Countries: United States
Sponsor: Butler Hospital
Condition: OCD

Behavioral study icon

CompletedNCT00915798

Association Between Smoking, Brain Activity, Genes, and ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Irvine
Condition: ADHD

Other study type icon

CompletedNCT01931644

At-Home Research Study for people with Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHD, Bipolarity, ...ObservationalFrom 18 Years to 100 Years

Countries: United States
Sponsor: Sanguine Biosciences
Condition: ADHD, Bipolarity, ...

Drug study icon

CompletedNCT00368849

Atomoxetine and Huntington's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Iowa
Condition: ADHD

Drug study icon

CompletedNCT00161031

Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00399763

Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHD, AddictionBehavioralFrom 12 Years to 19 Years

Countries: United States
Sponsor: Denver Health and Hospital Authority
Condition: ADHD, Addiction

Drug study icon

TerminatedNCT00299234

Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 18 Years

Countries: United States
Sponsor: Monarch Medical Research
Condition: ADHD

Behavioral study icon

CompletedNCT00254462

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 5 Years to 6 Years

Countries: United States
Sponsor: University of Nebraska
Condition: ADHD

Drug study icon

CompletedNCT00218543

Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

Drug study icon

CompletedNCT00142961

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 14 Years to 21 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

Behavioral study icon

CompletedNCT00176436

Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.